SCHEMBL23917549

SCHEMBL23917549

C=CC(=O)Nc1cc(-c2nn(C)c3ncnc(N)c23)ccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 9/20 0.59
PIK3CD O00329 9/20 0.59
PIK3CA P42336 9/20 0.59
PIK3CB P42338 9/20 0.59
PIK3CG P48736 9/20 0.59
PRKDC P78527 9/20 0.59
EGFR P00533 9/20 0.59
ABL1 P00519 8/20 0.59
HCK P08631 8/20 0.59
MTOR P42345 8/20 0.59
EPHB4 P54760 8/20 0.59
KDR P35968 7/20 0.59
PI4KB Q9UBF8 2/20 0.59
AURKA O14965 1/20 0.52
IKBKE Q14164 1/20 0.52
AURKB Q96GD4 1/20 0.52
LCK P06239 2/20 0.49
JAK3 P52333 1/20 0.48
BTK Q06187 1/20 0.48
ITK Q08881 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917279 0.92 SRC (0.62) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL23917545 0.81 SRC (0.58) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL16665789 0.79 JAK3 (0.43) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL130637 0.79 PIK3CD (0.81) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL23917276 0.76 PIK3CD (0.65) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL130418 0.76 PIK3CD (0.73) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL23917212 0.76 PIK3CD (0.79) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL16655763 0.75 BTK (0.51) SRCPIK3CDEGFRABL1HCK
SCHEMBL23917200 0.75 PIK3CD (1.00) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL13828434 0.74 RIPK1 (0.65) SRCPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB SRC 92/4885PIK3CD 2/4885PIK3CA 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.